Yannick Hoffert - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yannick Hoffert

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 9, 2025

Infliximab and Ustekinumab Clearance Better Predict Endoscopic Outcomes Than Trough Concentrations in Crohn's DiseaseZhigang Wang, Yannick Hoffert, Wei Zhang, et al.

CPT: Pharmacometrics & Systems Pharmacology|July 3, 2024

Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development toolJuan Francisco Morales, Marian Klose, Yannick Hoffert, et al.

Journal of Crohn'S & Colitis|March 24, 2026

Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitisEmmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 9, 2025

Infliximab and Ustekinumab Clearance Better Predict Endoscopic Outcomes Than Trough Concentrations in Crohn's DiseaseZhigang Wang, Yannick Hoffert, Wei Zhang, et al.

CPT: Pharmacometrics & Systems Pharmacology|July 3, 2024

Type 1 diabetes prevention clinical trial simulator: Case reports of model-informed drug development toolJuan Francisco Morales, Marian Klose, Yannick Hoffert, et al.

Journal of Crohn'S & Colitis|March 24, 2026

Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitisEmmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.

Pageof 2